TruBridge completed acquisition by IKS Health, shares delisted from Nasdaq
TruBridge, Inc. announced the completion of its acquisition by Inventurus Knowledge Solutions, Inc. (parent of IKS Health) on July 9, 2026. At the effective time, each outstanding share of TruBridge common stock was converted into the right to receive the per-share merger consideration. TruBridge ceased trading on Nasdaq prior to market opening on July 9, 2026 and will no longer be listed; the company requested Nasdaq file a Form 25 notification of removal and intends to file a Form 15 to terminate SEC registration.
Key facts
- IKS Health parent (Inventurus Knowledge Solutions, Inc.) funded acquisition through $635.0 million senior secured credit facilities, dated July 3, 2026
- TruBridge common stock ceased trading prior to opening of market on July 9, 2026
- All outstanding restricted stock awards automatically accelerated in full and converted to right to receive per-share merger consideration
- All performance share awards converted based on actual performance through effective time (or target performance if not determinable)
- Company paid off all outstanding indebtedness under Amended and Restated Credit Agreement with Regions Bank dated November 25, 2025
- All former TruBridge directors ceased serving; Joseph Bernardello, Peter Limeri and Taylor Curtis became directors of surviving corporation
- All incumbent TruBridge officers continued serving as officers of surviving corporation
- Combined organization supports more than 2,000 healthcare organizations and over 150,000 clinicians across U.S.
Why it matters
TruBridge is now a wholly owned subsidiary of IKS Health and no longer a public company; shareholders received merger consideration in exchange for common stock, and the company's equity incentive awards were either accelerated or converted based on performance through closing.
Developing story
- 25-NSE
- 8-Kthis filing
Share
Derived from 8-K filed 2026-07-09. Not investment advice. View the source filing on SEC.gov →